Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 44,278 shares at $7.02 ($311K) on 2020-01-22, disclosed to the SEC on 2020-01-24.
Seasonal sale ($311k) by Chief Operating Officer — this insider has traded STML in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.02 | 22,139 | $155K | 50.0% |
| 2 | $7.02 | 22,139 | $155K | 50.0% |
| Total | $7.02 avg | 44,278 | $311K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |
| STML | SELL | 2020-01-03 | $937K | — | Filing → |